Authors:
Hu, KF
Chen, M
Abusugra, I
Monaco, F
Morein, B
Citation: Kf. Hu et al., Different respiratory syncytial virus and Quillaja saponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profiles, FEMS IM MED, 31(2), 2001, pp. 105-112
Citation: I. Abusugra et B. Morein, Iscom is an efficient mucosal delivery system for Mycoplasma mycoides subsp. mycoides (MmmSC) antigens inducing high mucosal and systemic antibody responses, FEMS IM MED, 23(1), 1999, pp. 5-12
Authors:
Behboudi, S
Morein, B
Villacres-Eriksson, MC
Citation: S. Behboudi et al., Quillaja saponin formulations that stimulate proinflammatory cytokines elicit a potent acquired cell-mediated immunity, SC J IMMUN, 50(4), 1999, pp. 371-377
Authors:
Hu, KF
Ekstrom, J
Merza, M
Lovgren-Bengtsson, K
Morein, B
Citation: Kf. Hu et al., Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes, MED MICROBI, 187(4), 1999, pp. 191-198
Authors:
Wilson, AD
Lovgren-Bengtsson, K
Villacres-Ericsson, M
Morein, B
Morgan, AJ
Citation: Ad. Wilson et al., The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines, VACCINE, 17(9-10), 1999, pp. 1282-1290
Authors:
Ekstrom, J
Hu, KF
Bengtsson, KL
Morein, B
Citation: J. Ekstrom et al., Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions, VACCINE, 17(20-21), 1999, pp. 2690-2701
Authors:
Heeney, J
Akerblom, L
Barnett, S
Bogers, W
Davis, D
Fuller, D
Koopman, G
Lehner, T
Mooij, P
Morein, B
Morghen, CD
Rosenwirth, B
Verschoor, E
Wagner, R
Wolf, H
Citation: J. Heeney et al., HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates, IMMUNOL LET, 66(1-3), 1999, pp. 189-195
Authors:
van Pinxteren, LAH
Bruce, MG
Campbell, I
Wood, A
Clarke, CJ
Bellman, A
Morein, B
Snodgrass, DR
Citation: Lah. Van Pinxteren et al., Effect of oral rotavirus/iscom vaccines on immune responses in gnotobioticlambs, VET IMMUNOL, 71(1), 1999, pp. 53-67
Authors:
Verschoor, EJ
Davis, D
van Gils, M
Koopman, G
Mooij, P
Oostermeijer, H
Ten Haaft, P
Verstrepen, B
Rosenwirth, B
Morein, B
Barnett, SW
Heeney, JL
Citation: Ej. Verschoor et al., Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus, J MED PRIM, 28(4-5), 1999, pp. 224-232
Authors:
Cooray, R
Holmberg, M
Hellstrom, A
Hardig, J
Mattsson, R
Gunnarsson, A
Borjeson, H
Lindeberg, J
Morein, B
Citation: R. Cooray et al., Screening for microorganisms associated with M74 disease syndrome in sea-run Baltic salmon (Salmo salar), AMBIO, 28(1), 1999, pp. 77-81
Authors:
Verschoor, EJ
Mooij, P
Oostermeijer, H
van der Kolk, M
ten Haaft, P
Verstrepen, B
Sun, YD
Morein, B
Akerblom, L
Fuller, DH
Barnett, SW
Heeney, JL
Citation: Ej. Verschoor et al., Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in rhesus macaques: Evidence for viral clearance, J VIROLOGY, 73(4), 1999, pp. 3292-3300